Effect of a serotonin 1-A agonist on food intake of Osborne-Mendel and S5B/P1 rats

Physiology and Behavior

Volumn 68, Issue 5, 2000, Pages 715-722

  White, Christy L ^a   Kashima, Koji ^a   Bray, George A ^a   York, David A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

8 Hydroxy 2 (di n propylamino)tetralin; High fat diet; Osborne Mendel rats; S5B P1 rats; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN; SEROTONIN 1A RECEPTOR;

AGE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FAT INTAKE; FOOD INTAKE; FOOD PREFERENCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0034026448     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00243-7     Document Type: Article

References (49)

1. Bray G.A., Fisler J.S., York D.A. Neuroendocrine control of the development of obesity. understanding gained from studies of experimental animal models Front Neuroendocrinol. 11:1990;128-181.
2. Hill J.O., Lin D., Yakubu F., Peters J.C. Development of dietary obesity in rats. influence of amount and composition of dietary fat Int J Obes Relat Metab Disord. 16:1992;321-333.
3. Levin B.E. Sympathetic activity, age, sucrose preference, and diet-induced obesity. Obes Res. 1:1993;281-287.
4. Schemmell R., Mickelsen O., Gill J.L. Dietary obesity in rats. body weight and body fat accretion in seven strains of rats J Nutr. 100:1970;1041-1048.
5. Bray G.A., York D.A. The MONA LISA hypothesis in the time of leptin. Recent Prog Horm Res. 53:1998;95-118.
6. Okada S., York D.A., Bray G.A., Erlanson-Albertsson C. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase selectivity reduces fat intake. Physiol Behav. 49:1991;1185-1189.
7. Fisler J.S., Underberger S.J., York D.A., Bray G.A. d-Fenfluramine in a rat model of dietary fat-induced obesity. Pharmcol Biochem Behav. 45:1993;487-493.
8. Schemmel R.A., Teague R.J., Bray G.A. Obesity in Osborne-Mendel and S5B/P1 rats. effects of sucrose solutions, castration, and treatment with estradiol or insulin Am J Phsyiol. 243:1982;R347-R353.
9. Gilbertson T.A., Liu L., York D.A., Bray G.A. Dietary fat preferences are inversely correlated with peripheral gustatory fatty acid sensitivity. Ann NY Acad Sci. 855:1998;165-168.
10. Greenburg D., McCaffery J., Potack J.Z., Bray G.A., York D.A. Differential satiating effects of fats in the small intestine of obesity-resistant and obesity-prone rats. Phsyiol Behav. 66:1999;621-626.
11. Baez M., Kursar J.D., Helton L.A., Wainscott D.B., Nelson D.L.G. Molecular biology of serotonin receptors. Obes Res. 3:1995;441S-447S.
12. Dourish C.T. Multiple serotonin receptors. opportunities for new treatments for obesity? Obes Res. 3:1995;449S-462S.
13. Zifa E., Fillion G. 5-Hydroxytryptamine receptors (review). Pharmcol Rev. 44:1992;401-458.
14. Lucas J.J., Yamamoto A., Scearce-Levie K., Sandou F., Hen R. Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci. 18:1998;5537-5544.
15. 2C receptor mutant mice. Psychopharmacology (Berlin). 143:1999;309-314.
16. Dourish C.T., Hutson P.H., Curzon G. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(hi-n-propyamino) tetralin (8-OH-DPAT). Brain Res Bull. 15:1985;377-384.
17. Gilbert F., Dourish C.T. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT. Psychopharmacology (Berlin). 93:1987;349-352.
18. 1A receptors. Eur J Pharmcol. 150:1988;361-366.
19. Shimizu H., Fisler J.S., Bray G.A. Extracellular hypothalmaic monoamines measured by in vivo micro-dialysis in a rat model of dietary obesity. Obes Res. 2:1994;100-109.
20. Smith B.K., York D.A., Bray G.A. Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol Biochem Behav. 60:1998;105-114.
21. Blundell J.E., Hill A.J. Serotonergic drug potentates the satiating capacity of food-action of D-Fenfluaramine in obese subjects. Ann NY Acad Sci. 575:1989;493-495.
22. Veyrat-Durebex C., Alliot J. Changes in pattern of macronutrient intake during aging in male and female rats. Physiol Behav. 62:1997;1273-1278.
23. Veyrat-Durebex C., Boghossian S., Alliot J. Age-related changes in adaptive mechanisms of macronutrient self-selection. evidence for a sexual dimorphism Mech Ageing Dev. 103:1998;222-234.
24. Kanarek R.B., Feldman P.G., Hanes C. Pattern of dietary self-selection in VMF-lesioned rats. Physiol Behav. 27:1981;337-343.
25. Lin L., Chen J., York D.A. Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight. Peptides. 18:1997;657-661.
26. Lin L., York D.A., Bray G.A. comparison of Osborne-Mendle and S5B/Pl strains of rat. central effects of galanin, NPY, beta-casomorphin and CRH on intake of high-fat and low-fat diets Obes Res. 4:1996;117-124.
27. Singer L.K., York D.A., Bray G.A. Feeding response to mercaptoacetate in Osborne-Mendel and S5b/Pl rats. Obes Res. 5:1997;587-594.
28. Ookuma K., Barton C., York D.A., Bray G.A. Differential response to kappa-opioidergic agents in dietary fat selection between Osborne-Mendel and S5B/Pl rats. Peptides. 19:1998;141-147.
29. Okada S., York D.A., Bray G.A., Mei J., Erlanson-Albertsson C. Differential inhibition of fat intake in two strains of rat by the peptide enterostatin. Am J Physiol. 262:1992;R1111-R1116.
30. Nagase H., Bray G.A., York D.A. Effects of pyruvate and lactate on food-intake in rat strains sensitive and resistant to dietary obesity. Physiol Behav. 59:1996;555-560.
31. Nagase H., Bray G.A., York D.A. Pyruvate and hepatic pyruvate dehydrogenase levels in rat strains sensitive and resistant to dietary obesity. Am J Physiol. 270:1996;R489-R495.
32. Yoshida T., Fisler J.S., Fukushima M., Bray G.A., Schemmel R.A. Diet, lighting and food intake affect norepinephrine turnover in dietary obesity. Am J Physiol. 252:1987;R402-R408.
33. Buchanan T.A., Fisler J.S., Underberger S., Sipos G.F., Bray G.A. Whole body insulin sensitivity in Osborne-Mendel and S5B/P1 rats eating a low- or high-fat diet. Am J Physiol. 263:1992;R785-R789.
34. Fisler J.S., Yoshida T., Bray G.A. Catcholamine turnover in S5B/P1 and Osborne-Mendel rats. Am J Physiol. 247:1984;R290-R295.
35. Bray G.A., Teague R.J., Lee C.K. Brain uptake of ketones in rats with differing susceptibility to dietary obesity. Metabolism. 36:1987;27-30.
36. Garattini S. Biological actions of drugs affecting serotonin and eating. Obes Res. 3:1995;463S-470S.
37. Fletcher P.J., Coscina D.V. Injecting 5-HT into the PVN does not prevent feeding induced by injecting 8-OH-DPAT into the raphe. Pharmacol Biochem Behav. 46:1993;487-491.
38. Hutson P.H., Dourish C.T., Curzon G. Neurochemical and behavioral evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol. 129:1986;347-352.
39. 1B receptors in the control of feeding in rats. Life Sci. 41:1987;635-642.
40. Dourish C.T., Hutson P.H., Curzon G. Effects of 5-HT depletion and of 5-HT and catecholamine receptor antagonists on 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)-induced feeding in the rat. Soc Neurosci Abstr. 12:1986;1190.
41. Dourish C.T., Hutson P.H., Curzon G. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist -8-OH-DPAT. Psychopharmacology (Berlin). 89:1986;467-471.
42. Orthen-Gambill N., Kanarek R.R. Differential effects of amphetamine and fenfluramine on dietary self-selection in rats. Pharmacology. 16:1982;303-309.
43. Shor-Posner G., Grinker J.A., Marinescu C., Brown O., Leibowitz S.F. Hypothalamic serotonin in the control of meal pattersn and macronutrient selection. Brain Res Bull. 17:1986;663-671.
44. Drent M.L., Zelissen P.M., Koppeschaar H.P., Nieuwenhuyzen Kruseman A.C., Lutterman J.A., van der Veen E.A. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks. Int J Obes Relat Metab Disord. 19:1995;299-304.
45. Goodall E., Cowen P.J., Franklin M., Silverstone T. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacoloy (Berlin). 112:1993;461-466.
46. Erlanson-Albertsson C., York D.A. Enterostatin - a peptide regulating fat intake. Obes Res. 5:1997;360-372.
47. Wurtman J.J., Wurtman R.J., Growdon J.H., Henry P., Lipscomb A., Zeisel S.H. Carbohydrate craving in obese people suppression by treatments affecting serotonergic transmission. Int J Eat Disord. 1:1981;2-15.
48. Blundell J.E., Lawton C.L. Serotonin and dietary fat intake. effects of dexfenfluramine Metabolism. 44:1995;33-37.
49. Goodall E., Feeney S., McGuirk J., Silverstone T. A comparison of the effects of d- and l-fenfluramine and d-amphetamine on energy and macronutrient intake in human subjects. Psychopharmcology (Berlin). 106:1992;221-227.